Company news
TransMedics Group, Inc. news in 2021
TransMedics Group, Inc.'s news releases, calls and decks from 2021, newest first.
TransMedics to Present at the 40th Annual J.P. Morgan Healthcare Conference
December 21, 2021
TransMedics Reports Third Quarter 2021 Financial Results
November 8, 2021
TransMedics to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum
November 3, 2021
TransMedics Announces Positive Top Line Results From the U.S. Randomized OCS DCD Heart Trial
November 3, 2021
TransMedics to Report Third Quarter 2021 Financial Results on November 9, 2021
October 25, 2021
TransMedics Receives FDA Approval for its OCS Liver System for Preservation and Assessment of Donor Livers for Transplantation
September 28, 2021
TransMedics Receives FDA Approval for its OCS Heart System Enabling Broader Utilization of Donor Hearts for Transplantation in the U.S.
September 6, 2021
TransMedics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
August 25, 2021
TransMedics Reports Second Quarter 2021 Financial Results
August 4, 2021
TransMedics Receives FDA Clearance of OCS Lung Solution for Cold Preservation of Lungs
July 28, 2021
TransMedics to Participate in the Canaccord Genuity 41st Annual Growth Conference
July 27, 2021
TransMedics to Report Second Quarter 2021 Financial Results on August 5, 2021
July 21, 2021
TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Liver System
July 13, 2021
TransMedics Announces Positive FDA Advisory Committee Vote for the OCS Liver System
July 13, 2021
TransMedics Announces Scheduling of OCS Liver FDA Advisory Committee Meeting
June 9, 2021
TransMedics Announces Presentation of OCS Liver PROTECT Trial Results and is Recognized as Winner of The People's Choice Award for Most Impactful Presentation at the American Transplant Congress (ATC 2021)
June 7, 2021
TransMedics Reports First Quarter 2021 Financial Results
May 3, 2021
TransMedics to Report First Quarter 2021 Financial Results on May 4, 2021
April 19, 2021
TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Heart System
April 5, 2021
TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System
April 5, 2021
TransMedics Appoints Stephanie Lovell to Board of Directors
March 23, 2021
TransMedics Reports Fourth Quarter and Full Year 2020 Financial Results
March 1, 2021
TransMedics Announces Scheduling of OCS Heart FDA Advisory Committee Meeting
February 28, 2021
TransMedics to Report Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021
February 15, 2021
TransMedics to Present at the Cowen 41st Annual Healthcare Conference
February 15, 2021